Onyx Pharmaceuticals Inc
update 11:07
86.81
-2.00 (-2.24%%)
TODAY
High 88.80
Low 85.72
Open 88.25
Volume 331503
Time 11:07
52 WEEK SUMMARY
High 101.56
Low 44.00
P/E 0.00
Return
96.49%
Mkt Cap
6.293 B
Onyx Pharmaceuticals, Inc. discovers and develops novel therapeutics based upon the genetics of human disease, with an emphasis on cancer. The Company focuses on defining the function of certain mutated genes which are known to cause cancer, and on developing therapies to reverse the effects of the mutation or to kill the cancer cell.
%7Cutmccn%3D(direct)%7Cutmcmd%3D(none);&utmn=156273757&utmp=%2Fquote%2FONXX%3AUS%3Fcount%3D5&utmhn=10.248.179.17&utmac=UA-11413116-12&utmhid=648698708)